Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

RusHydro increased generation by 2.8%

1/30/25 HYDR

Lukoil postpones exploration drilling at Severo-Tylenevskaya until 2027

1/30/25 LKOH

Promomed registered the first fully Russian tirzepatide

1/30/25 PRMD

Novatek connected a new gas carrier for LNG transshipment in Murmansk

1/30/25 NVTK

Moscow Exchange will launch an index of shareholder value creation for companies

1/30/25 MOEX

Sollers launched a full cycle of production of pickup trucks ST6 and ST8

1/30/25 SVAV

Sollers raised the Net Debt/ EBITDA threshold for dividends

1/30/25 SVAV

Fix Price in 2025 plans in Kazakhstan to open at least 60 stores

1/30/25 FIXP

Rusal will double capacity to produce aluminum powders and pastes

1/30/25 RUAL

Fesco increased container transportation between India and Novorossiysk by 7 times

1/30/25 FESH